Title:
CRYSTALLINE FORM OF SULFUR-CONTAINING ISOINDOLINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2023/138647
Kind Code:
A1
Abstract:
The present disclosure relates to a crystalline form of a sulfur-containing isoindoline derivative. Specifically, the present disclosure relates to a crystalline form of a compound as represented by formula (I) and a preparation method therefor.
Inventors:
ZHANG BAOLEI (CN)
XI ZHUOXUN (CN)
FENG JUN (CN)
HE FENG (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
XI ZHUOXUN (CN)
FENG JUN (CN)
HE FENG (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
Application Number:
PCT/CN2023/073077
Publication Date:
July 27, 2023
Filing Date:
January 19, 2023
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/14; A61K31/454; A61P35/00
Domestic Patent References:
| WO2022017365A1 | 2022-01-27 | |||
| WO2008115516A2 | 2008-09-25 | |||
| WO2021055756A1 | 2021-03-25 |
Foreign References:
| CN112492874A | 2021-03-12 | |||
| CN102822165A | 2012-12-12 | |||
| CN110869021A | 2020-03-06 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: